Aspirin is indicated for primary prevention of cardiovascular events in HIV-infected patients

Journal of Acquired Immune Deficiency Syndromes

Volumn 54, Issue 5, 2010, Pages 560-

  Tornero, Carlos ^a   Ventura, Ana ^a   Mafe, Maricarmen ^a  

^a Hospital Gandia   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; PRIMARY PREVENTION; PRIORITY JOURNAL; SMOKING HABIT;

AGED; ASPIRIN; CARDIOVASCULAR DISEASES; CHEMOPREVENTION; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PRIMARY PREVENTION;

EID: 77954960953     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181d913fd     Document Type: Letter

References (4)

1. US preventive Services Task Force. Aspirin for the prevention of cardiovascular disease: US preventive services task force recommendation statement. Ann Intern Med. 2009;150:396-404.
2. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837-1847.
3. Friis-Moller N, Sabin CA, Weber R, et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med. 2003; 349:1993-2003.
4. D:A:D Study group. Class of antiretroviral drugs and the risk of myocardial infarction in HIV infected patients. N Engl J Med. 2007;356: 1723-1735.